Expression and clinical value of serum thymidine kinase 1 in patients with acute exacerbation of chronic obstructive pulmonary disease
10.3969/j.issn.1006-5725.2015.09.014
- VernacularTitle:血清胸苷激酶1在慢性阻塞性肺疾病急性加重期患者中的临床价值
- Author:
Yin LIU
;
Mengmeng JIN
;
Zhendong QIAN
;
Meili CHEN
;
Rui HUANG
;
Ting DU
;
Yanbei ZHANG
- Publication Type:Journal Article
- Keywords:
Acute exacerbation of chronic obstructive pulmonary disease;
Serum thymidine kinase 1;
Efficacy
- From:
The Journal of Practical Medicine
2015;(9):1431-1433
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the relations and evaluation value of serum thymidine kinase 1 (sTK1) in the treatment of patients withacute exacerbation of chronic obstructive pulmonarydisease (AECOPD). Methods The retrospective treating studies were performed on 104 patients with AECOPD , sTK1 level was de-tected by chemiluminescence dot-blot assay before and after treatment , and the correlation between the expression of sTK1 and CRP after treatment in the two groups was analyzed. Results The levels of sTK1 and CRP in the ef-fective group significantly lowered after treatment (P < 0.05). The expression of sTK1 in the effective group and in the ineffective group after treatment was significantlycorrelated with CRP (P < 0.05). Conclusion sTK1 can be used as a valuable indicator to evaluate the severity of AECOPD and to estimate the efficacy of AECOPD thera-py.